Danuta Sorysz

Danuta Sorysz

Auto-generated profile, based on publicly available information

Danuta Sorysz

II Department of Cardiology, CMUJ University Hospital, Krakow, Poland (D.S.).

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
TTTomasz Tokarek
Tomasz Tokarek
Artur DziewierzArtur Dziewierz
Artur Dziewierz
AWAgata Wiktorowicz
Agata Wiktorowicz
MBMaciej Bagienski
Maciej Bagienski
ŁRŁukasz Rzeszutko
Łukasz Rzeszutko
DDDariusz Dudek
Dariusz Dudek
Diabetes mellitus (DM) is considered a marker of poor prognosis after cardiac surgery. We sought to investigate the effect of DM on clinical outcomes and quality of life (QoL) after transcatheter aortic valve implantation (TAVI). A total of 148 consecutive patients with symptomatic, severe aortic stenosis who underwent TAVI were included. Baseline characteristics, procedural and long-term clinical outcomes, and the results of frailty and QoL assessment with EQ-5D-3L questionnaire were compared between patients with and without DM. DM was present in 48 of 148 (32.4%) patients. No differences in periprocedural risk (Logistic Euroscore and Society of Thoracic Surgeons (STS) scale) between groups were observed. There were no differences in 30-day and 12-month all-cause mortality between groups [DM(-) vs. DM(+): 7 (7.0%) vs. 5 (10.4%), p = 0.53 and 12 (12.0%) vs. 10 (20.8%), p = 0.16, respectively]. No influence of DM presence on the risk of death was confirmed after adjustment for age and gender (for 30-day mortality, age/gender-adjusted OR 1.55, 95%CI 0.47-5.17; for 12-month mortality, age/gender-adjusted OR 2.05, 95%CI 0.79-5.32). Similarly, at the longest available follow-up, mortality did not differ between groups [14 (29.2%) vs. 19 (19.0%), p = 0.16; age/gender-adjusted OR 1.81, 95%CI 0.80-4.08]. Similar rates of other complications after TAVI were noted. Frailty measured with the 5-meter walking test was more frequently reported in patients with DM [11 (22.9%) vs. 10 (10.0%), p = 0.035]. No differences in QoL parameters at baseline and 12 months were noted. Patients with DM undergoing TAVI demonstrated similar mortality, complication rates, and QoL outcomes compared to patients without DM.

12 August 2016 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MDMarzena Daniec
Marzena Daniec
BNBartłomiej Nawrotek
Bartłomiej Nawrotek
DSDanuta Sorysz
Danuta Sorysz
TRTomasz Rakowski
Tomasz Rakowski
Artur DziewierzArtur Dziewierz
Artur Dziewierz
DDDariusz Dudek
Dariusz Dudek

18 August 2017 in Polish Heart Journal
Verified
Journal Article
Open access
PDF file
PKPawel Kleczynski
Pawel Kleczynski
Artur DziewierzArtur Dziewierz
Artur Dziewierz
MDMarzena Daniec
Marzena Daniec
MBMaciej Bagieński
Maciej Bagieński
ŁRŁukasz Rzeszutko
Łukasz Rzeszutko
DDDariusz Dudek
Dariusz Dudek
Background: Post-implantation paravalvular leak (PVL) remains a significant complication of transcatheter aortic valve implantation (TAVI). More importantly, its occurrence may impact long-term mortality. Aim: We sought to evaluate the effects of balloon post-dilatation (PD) on the reduction of PVL and mortality in patients undergoing TAVI. Methods: A total of 101 consecutive patients undergoing TAVI were enrolled. Angiography, echocardiography, and the aortic regurgitation index (ARI) were used to assess the severity of PVL before and after balloon PD. Patients were divided into two groups based whether or not PD after TAVI was performed. Reduction of PVL, change of ARI, and clinical outcomes were assessed. Results: Balloon post-dilatation was performed in 23 (22.8%) patients. In 95.6%, PVL reduction was successful (no or mild PVL). PD increased the ARI from 23.4% (22.4–24.0) to 27.1% (26.1–28.3); p < 0.001. Thirty-day mortality rate was 14.1% in the PD (–) group vs. 0.0% in the PD (+) group; p = 0.07. One-year mortality (21.8% vs. 4.3%, p = 0.97) and procedural stroke rate (7.7% vs. 8.7%, p = 0.99) were not different between the groups. Conclusions: Balloon post-dilatation may be a safe and effective technique to reduce moderate to severe PVL after TAVI. Background: Post-implantation paravalvular leak (PVL) remains a significant complication of transcatheter aortic valve implantation (TAVI). More importantly, its occurrence may impact long-term mortality. Aim: We sought to evaluate the effects of balloon post-dilatation (PD) on the reduction of PVL and mortality in patients undergoing TAVI. Methods: A total of 101 consecutive patients undergoing TAVI were enrolled. Angiography, echocardiography, and the aortic regurgitation index (ARI) were used to assess the severity of PVL before and after balloon PD. Patients were divided into two groups based whether or not PD after TAVI was performed. Reduction of PVL, change of ARI, and clinical outcomes were assessed. Results: Balloon post-dilatation was performed in 23 (22.8%) patients. In 95.6%, PVL reduction was successful (no or mild PVL). PD increased the ARI from 23.4% (22.4–24.0) to 27.1% (26.1–28.3); p < 0.001. Thirty-day mortality rate was 14.1% in the PD (–) group vs. 0.0% in the PD (+) group; p = 0.07. One-year mortality (21.8% vs. 4.3%, p = 0.97) and procedural stroke rate (7.7% vs. 8.7%, p = 0.99) were not different between the groups. Conclusions: Balloon post-dilatation may be a safe and effective technique to reduce moderate to severe PVL after TAVI.

25 August 2020 in Polish Heart Journal
Verified
Journal Article
Open access
DSDanuta Sorysz
Danuta Sorysz
Artur DziewierzArtur Dziewierz
Artur Dziewierz
MBMaciej Bagieński
Maciej Bagieński
RPRadoslaw Parma
Radoslaw Parma
MGMarek Grygier
Marek Grygier
DDDariusz Dudek
Dariusz Dudek
DOI: 10.33963/KP.15426, Published online: June 08, 2020, Authors: Danuta Sorysz, Artur Dziewierz, Maciej Bagieński, Radosław Parma, Marek Grygier, Marcin Dębiński, Piotr Kübler, Maciej Stąpór, Dariusz Jagielak, Kleczyński Paweł, Stanisław Bartuś, Dariusz Dudek

1 January 2024 in Advances in Interventional Cardiology
Verified
Journal Article
Open access
DSDanuta Sorysz
Danuta Sorysz
ADArtur Dziewierz
Artur Dziewierz
KGKatarzyna Gawlik
Katarzyna Gawlik
MOMarta Opalińska
Marta Opalińska
ASAnna Sowa Staszczak
Anna Sowa Staszczak
DDDariusz Dudek
Dariusz Dudek
Introduction: As transcatheter aortic valve implantation (TAVI) indications expand, understanding the valve degeneration process and potential influencing biomarkers becomes increasingly important. Aim: To investigate temporal changes in biomarker levels and their potential association with...

14 October 2024 in American Journal of Case Reports
Verified
Journal Article
Open access
EDEmil Dadański
Emil Dadański
AOAgnieszka Olszanecka
Agnieszka Olszanecka
DSDanuta Sorysz
Danuta Sorysz
WWWiktoria Wojciechowska
Wiktoria Wojciechowska
BCBernadeta Chyrchel
Bernadeta Chyrchel
MRMarek W Rajzer
Marek W Rajzer
BACKGROUND Echogenic masses in the mitral annulus are often incidental findings during routine echocardiography examinations. Most represent the wide spectrum of underlying mitral annular calcifications and usually do not require further diagnostic workup. However, a rare variant called "caseous calcification of the mitral annulus" (CCMA) can be challenging to diagnose and often requires an extensive workup with the use of multiple imaging studies in order to accurately confirm the pathology. CASE REPORT The aim of this case series was to illustrate the range of challenges associated with CCMA in various clinical scenarios to highlight the importance of multi-modality imaging in the differential diagnosis. Patient 1 was a 78-year-old asymptomatic woman with a round echo-dense structure incidentally found during a routine echocardiographic examination. Patient 2 was a 79-year-old woman with a suspected mitral abscess. Patient 3 was a 73-year-old woman with an incidentaloma (lung mass), with a concomitant lesion of the mitral annulus. All 3 patients required a unique combination of confirmatory imaging studies to ultimately confirm their diagnosis. CONCLUSIONS The incidental detection of CCMA-like changes requires multi-modality imaging to differentiate from abscesses and proliferative changes in the mitral annulus. Transthoracic echocardiography, transesophageal echocardiography, computed tomography, and cardiac magnetic resonance imaging play a key role in this diagnostic workup. Using a combination of these imaging modalities can enhance diagnostic accuracy and strongly influence the subsequent treatment and management strategies.